Symogen

Symogen is a UK-based, privately-held service provider founded in 2017, operating in the biopharmaceutical and medical device sectors. The company offers a comprehensive suite of regulatory science and safety services, including pharmacovigilance, medical writing, and quality assurance, catering to a global clientele. It differentiates itself by integrating process automation, machine learning, and big data analytics into its service delivery. With over 18 years of collective experience claimed by its team, Symogen positions itself as a strategic partner for ensuring regulatory compliance and product safety from clinical development through post-marketing.

Symogen integrates Process Automation, Machine Learning, and Big Data analytics into its pharmacovigilance and regulatory service workflows. Applications include automated data entry, speech recognition, ML-driven case triage, literature review, and quality control processes.

Symogen competes in a fragmented market with large, full-service Contract Research Organizations (CROs), other specialized pharmacovigilance service providers, and offshore outsourcing firms. Its differentiation is based on a combination of deep regulatory expertise, a technology-enabled service platform, and a global delivery model emphasizing quality and cultural awareness.